Privacy Policy & Disclaimer

Last updated: 2 July 2026

DrugRadar ("the app") is an information tool that lists recently approved pharmaceutical drugs and late-stage clinical trials, shows estimated regulatory decision dates, extracts structured "at a glance" facets from approved-indication text, can generate optional on-device reminders, and offers convenience features such as private notes, a glossary of regulatory terms, side-by-side comparison views (including full-text EU SmPC and US FDA label sections, and an EU-vs-US label comparison for the same medicine), and sharing of drug summaries — all drawing on publicly available regulatory data. This policy explains how the app handles your information and the terms on which the information is provided. In short: it does not collect any personal data, and it is not medical advice.

Data we collect

None. DrugRadar does not require an account, does not ask for your name, email, or any personal details, and does not include any analytics, advertising, or third-party tracking technologies.

Information stored on your device

The app stores the following locally on your device only:

• a timestamp of your last visit, to highlight entries that are new since you last opened the app;
• the list of medical indications you choose to follow, and identifiers for the reminders scheduled from them;
• any personal notes you write on a medicine (visible only inside the app on this device);
• a cached copy of the most recently fetched public reference data, and the time it was last updated, so the app works offline.

None of this is linked to your identity, and none of it is transmitted to us or anyone else. Any reminders are generated and delivered entirely on your device. Removing the app deletes all of it.

Network requests

To display its content, the app requests publicly available data, over an encrypted (HTTPS) connection, from official public sources, including:

• openFDA (U.S. Food & Drug Administration) — open.fda.gov
• ClinicalTrials.gov (U.S. National Library of Medicine) — clinicaltrials.gov
• European Medicines Agency (EMA) — ema.europa.eu

These requests retrieve public reference data only. The app does not send any personal information to these services. Each service operates under its own privacy policy.

Data sharing

Because the app collects no personal data, there is nothing for us to share, sell, or disclose. The app does offer a user-initiated "Share" action that opens the standard system share sheet with a plain-text summary of a medicine's public regulatory data. What happens to that text is entirely under your control; it is composed only of public reference data and never includes your private notes, your watchlist, or anything else stored on your device. The user-initiated "Add to Calendar" action works the same way: it hands a calendar file (.ics) containing only public regulatory data and estimated decision dates to the system share sheet — importing it into your calendar is entirely your action, and the event text itself notes that the date is an estimate that may change or never occur.

Children's privacy

The app is a general-audience information tool and does not knowingly collect any data from anyone, including children.

Medical & liability disclaimer

DrugRadar presents public regulatory information for general informational purposes only. It is not medical advice, not a clinical decision support tool, and not a substitute for professional medical judgment, official regulatory sources, or consultation with a qualified healthcare professional. Nothing in the app should be used to diagnose, treat, prescribe for, or make any clinical, regulatory, or commercial decision about any patient or product.

The app is intended as a reference aid for healthcare professionals and others following drug-regulatory developments. It is not intended for patients or consumers to self-diagnose or self-medicate, and it is not for use in a medical emergency — if you may have a medical emergency, contact your local emergency service. Using the app creates no doctor–patient or other professional relationship. Any clinical decision remains the sole responsibility of the treating, appropriately qualified healthcare professional, based on the official product information and the individual patient.

Please note in particular:

• The data may be incomplete, delayed, or wrong. It is aggregated from the FDA, EMA, and ClinicalTrials.gov; European and curated lists are periodic snapshots, and any sponsor "PDUFA" target dates are unofficial.
• Estimated decision dates are estimates. Expected European Commission decision dates are calculated from the CHMP opinion date and are approximate; the actual decision, its timing, and its outcome may differ or may not occur.
• The "at a glance" indication facts are automatically extracted from text (biomarker, line of therapy, setting, and similar) and may be inaccurate or incomplete. They are a reading aid only — always read the full approved indication and verify it against the official SmPC / EPAR or FDA label.
• Regulatory authorisation is not the same as availability. A medicine may be authorised yet not reimbursed, not launched, or not available in your country. The app does not track national reimbursement, pricing, or availability.
• Reminders are a convenience, not a guarantee. On-device reminders may be delayed or may not appear, and are not official notifications from any authority.
• Glossary entries are simplified summaries. The built-in explanations of regulatory terms (e.g. PRIME, ATMP, conditional marketing authorisation, PDUFA) are short orientation aids, not legal or regulatory advice; the official EMA/FDA definitions linked from each entry are authoritative.
• The comparison views and shared summaries are derived displays. They re-present the same underlying data — including estimated dates and auto-extracted facets — and carry all of the limitations above. A shared summary is a snapshot that may be out of date by the time it is read.
• Full-text label sections are abbreviated snapshots. The side-by-side comparison shows text extracted automatically from EMA product-information PDFs (SmPC, Annex I) and from US FDA labels (via the openFDA drug-label API). Sections may be truncated, may contain extraction errors, and reflect the document as at the snapshot date — the label may since have been revised. The live linked document (EMA SmPC / FDA label on DailyMed) is the only authoritative version. The EU SmPC and the US Prescribing Information are separate legal documents with different approved indications, warnings, dosing and populations, and each applies only in its own jurisdiction — they are not interchangeable. Nothing shown here may be relied on for prescribing, dosing, or any treatment decision.
• Your notes are your own content. Personal notes are stored only on your device, are never reviewed or verified by anyone, and form no part of the app's reference data.

Always verify any entry against its primary source before relying on it. The app is provided "as is" and "as available", without warranties of any kind, whether express, implied, or statutory, including any implied warranties of accuracy, completeness, currency, non-infringement, merchantability, or fitness for a particular purpose. To the maximum extent permitted by applicable law, the author and any contributors accept no liability whatsoever for any direct, indirect, incidental, special, consequential, or punitive loss, injury, or damage — including harm to any patient — arising from or in connection with the use of, or reliance on, the app or its content, even if advised of the possibility of such damage. You use the app entirely at your own risk.

Some jurisdictions do not allow the exclusion of certain warranties or the limitation of certain liabilities, so some of the above may not apply to you. Nothing in this disclaimer excludes or limits any liability that cannot be excluded or limited under applicable law — including, where applicable, liability for death or personal injury caused by negligence. If any provision is held unenforceable, the remaining provisions continue in full effect. This disclaimer does not affect any mandatory statutory rights you may have as a consumer.

Changes to this policy

If this policy changes, the revised version will be posted on this page with an updated date.

Contact

Questions about this policy? Email bernd.gansbacher@gmail.com.